Data / Drug companies / Publix Super Markets, Inc
Publix Super Markets, Inc: 48 products in the FDA NDC directory, labeler code 41415
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Publix Super Markets, Inc (labeler code 41415) lists 48 products in the FDA National Drug Code Directory, covering 25 finished drugs by generic name. By type: 48 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on July 15, 2026.
The request: Watch Publix Super Markets, Inc (FDA labeler code 41415): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 41415
- Products in commercial distribution
- 48
- Packages
- 58
- Finished drugs by generic name
- 25
- Prescription products
- 0
- Over the counter products
- 48
- Flagged as original packager
- 22 of 22 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- October 3, 1989
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 41 | 85.4% |
| Generic drugs (ANDA) | 7 | 14.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 48 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Calcium carbonate | 6 | 101 |
| Psyllium husk | 3 | 14 |
| Oxymetazoline hydrochloride | 3 | 64 |
| Acetaminophen | 3 | 214 |
| Simethicone | 3 | 86 |
| Bismuth subsalicylate | 3 | 80 |
| Hydrocortisone | 2 | 171 |
| Zinc acetate and pramoxine hydrochloride | 2 | 9 |
| Phenol | 2 | 31 |
| Guaifenesin and dextromethorphan hbr | 2 | 26 |
| Menthol | 2 | 263 |
| Guaifenesin | 2 | 123 |
| Bisacodyl | 2 | 60 |
| Acetaminophen and diphenhydramine hcl | 1 | 6 |
| Fexofenadine hydrochloride and pseudoephedrine hydrochloride | 1 | 16 |
| Docosanol | 1 | 42 |
| Phenylephrine hydrochloride | 1 | 77 |
| Guaifenesin and pseudoephedrine hydrochloride | 1 | 15 |
| Calcium polycarbophil | 1 | 33 |
| Nasal | 1 | 12 |
| Povidone iodine 10% | 1 | 11 |
| Hydrocortisone cream 1% with aloe | 1 | 1 |
| Calcium sennosides | 1 | 1 |
| Bacitracin zinc, neomycin sulfate, and polymyxin b | 1 | 1 |
| Clotrimazole | 1 | 98 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 8 | 16.7% |
| Spray | 7 | 14.6% |
| Cream | 6 | 12.5% |
| Tablet | 6 | 12.5% |
| Tablet, extended release | 6 | 12.5% |
| Powder | 2 | 4.2% |
| Lotion | 2 | 4.2% |
| Lozenge | 2 | 4.2% |
| Suspension | 2 | 4.2% |
| Capsule | 1 | 2.1% |
| Capsule, liquid filled | 1 | 2.1% |
| Tablet, coated | 1 | 2.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Acetaminophen | 41415-175 | Tablet | Over the counter monograph drugs | July 15, 2026 |
| Hydrocortisone Cream 1% | 41415-330 | Cream | Over the counter monograph drugs | April 13, 2026 |
| Docosanol | 41415-660 | Cream | Generic drugs (ANDA) | July 15, 2025 |
| Acetaminophen | 41415-538 | Tablet | Over the counter monograph drugs | September 9, 2024 |
| Acetaminophen and Diphenhydramine HCL | 41415-661 | Tablet | Over the counter monograph drugs | August 2, 2024 |
| Acetaminophen | 41415-177 | Tablet | Over the counter monograph drugs | August 2, 2024 |
| PUBLIX Sore Throat Menthol Flavor | 41415-307 | Spray | Over the counter monograph drugs | November 1, 2022 |
| PUBLIX Stomach Relief Ultra Strength | 41415-707 | Suspension | Over the counter monograph drugs | October 24, 2022 |
| PUBLIX Regular Strength Pink Bismuth | 41415-706 | Suspension | Over the counter monograph drugs | October 24, 2022 |
| PUBLIX Sore Throat Fast Relief Oral Anesthetic | 41415-703 | Spray | Over the counter monograph drugs | October 24, 2022 |
| Guaifenesin and Pseudoephedrine Hydrochloride | 41415-994 | Tablet, extended release | Generic drugs (ANDA) | April 7, 2022 |
| Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride | 41415-995 | Tablet, extended release | Generic drugs (ANDA) | November 8, 2021 |
| Guaifenesin and Dextromethorphan HBr | 41415-999 | Tablet, extended release | Generic drugs (ANDA) | July 1, 2021 |
| Guaifenesin and Dextromethorphan HBr | 41415-998 | Tablet, extended release | Generic drugs (ANDA) | July 1, 2021 |
| Saline | 41415-477 | Spray | Over the counter monograph drugs | January 27, 2021 |
| Extra Strength Sugar Free Orange Cream Flavor | 41415-296 | Tablet, chewable | Over the counter monograph drugs | May 23, 2019 |
| Publix Extra Strength Tropical Fruit | 41415-201 | Tablet, chewable | Over the counter monograph drugs | May 22, 2019 |
| Publix Women Laxative | 41415-121 | Tablet | Over the counter monograph drugs | May 22, 2019 |
| Publix Stimulant Laxative | 41415-116 | Tablet, coated | Over the counter monograph drugs | May 22, 2019 |
| Publix Regular Strength Peppermint Flavor | 41415-111 | Tablet, chewable | Over the counter monograph drugs | May 22, 2019 |
| Publix | 41415-119 | Capsule | Over the counter monograph drugs | May 21, 2019 |
| Publix Ultra Strength Assorted Fruit | 41415-103 | Tablet, chewable | Over the counter monograph drugs | May 21, 2019 |
| Publix | 41415-021 | Tablet, film coated | Over the counter monograph drugs | May 21, 2019 |
| Publix | 41415-728 | Spray | Over the counter monograph drugs | May 20, 2019 |
| Publix Fiber Therapy Sugar Free | 41415-515 | Powder | Over the counter monograph drugs | May 20, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.